Monthly intelligence on cross-border pharma deals. Plus live partnership opportunities from Chinese companies actively seeking Western partners.
Monthly. No spam. Unsubscribe anytime.
One email, every month. No noise.
Licensing, co-development, supply agreements. The five most strategically significant cross-border deals, ranked and explained.
Chinese pharma companies actively seeking Western partners, featured every month. Products, pipelines, and platforms available for licensing, co-development, or distribution.
Every deal is scored for relevance to Western BD teams. We tell you what to watch, what to ignore, and what to act on.
Monthly intelligence on cross-border pharma deals. Plus live partnership opportunities from Chinese companies actively seeking Western partners.
Unsubscribe anytime. No spam, ever.